Results 171 to 180 of about 389,483 (184)

Cost Evaluation of Surgical and Pharmaceutical Options in Treatment for Vitreomacular Adhesions and Macular Holes

Ophthalmology, 2014
Jonathan Chang, William E Smiddy
exaly  

Ocriplasmin cost effective in symptomatic vitreomacular adhesion

PharmacoEconomics & Outcomes News, 2020
openaire   +1 more source

Intravitreal Gas for Symptomatic Vitreomacular Adhesion: A Synthesis of the Literature

Acta Ophthalmologica, 2018
James E Neffendorf, Riti Desai, Timothy Jackson   +2 more
exaly  

Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study

Ophthalmology Retina, 2019
Peter K Kaiser, Petra Kozma, Brian C Joondeph   +2 more
exaly  

Vitreomacular Adhesion and Its Association With Age-Related Macular Degeneration in a Population-Based Setting: The Alienor Study

Investigative Ophthalmology and Visual Science, 2017
Marie-Bénédicte Rougier, Audrey Cougnard-Grégoire, Cécile Delcourt   +2 more
exaly  

What are the effects of ocriplasmin for people with symptomatic vitreomacular adhesion?

Cochrane Clinical Answers, 2018
Sera Tort, Asaf Achiron
openaire   +1 more source

Comment On: Vitreomacular Adhesion and Its Association With Age-Related Macular Degeneration in a Population-Based Setting: The Alienor Study

Investigative Ophthalmology and Visual Science, 2017
Emilia Maggio, Grazia Pertile
exaly  

Full-Thickness Macular Hole and Symptomatic Vitreomacular Adhesion: Comparison of Visual Results in Patients Receiving Pars Plana Vitrectomy in One Eye and Ocriplasmin in the Fellow Eye

Journal of Vitreoretinal Diseases, 2019
Arshad M Khanani, Joseph M Coney, Greggory M Gahn   +2 more
exaly  

Ocriplasmin for symptomatic vitreomacular adhesion.

Technology Evaluation Center Assessment Program. Executive summary, 2013
openaire   +1 more source

Ocriplasmin (Jetrea) for vitreomacular adhesion.

The Medical letter on drugs and therapeutics, 2013
openaire   +1 more source